title: Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
authors.affiliation: Bayer Pharma AG, Global Biomarker Research, 42096 Wuppertal, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Schlange
authors.affiliation: Department of Tumour Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Pantel
mesh_terms: D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood* / Q000235:genetics; D015815:Cell Adhesion Molecules / Q000097:blood; D002469:Cell Separation; D004273:DNA, Neoplasm / Q000097:blood; D000071858:Epithelial Cell Adhesion Molecule; D058750:Epithelial-Mesenchymal Transition; D006801:Humans; D017493:Leukocyte Common Antigens / Q000097:blood; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D009360:Neoplastic Cells, Circulating / Q000378:metabolism / Q000473:pathology*; D057285:Precision Medicine
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015815:Cell Adhesion Molecules; D004273:DNA, Neoplasm; D000071858:Epithelial Cell Adhesion Molecule; D017493:Leukocyte Common Antigens
keywords: blood-based biomarkers; circulating tumor cells; liquid biopsy; personalized medicine; tumor heterogeneity